v3.25.1
Unaudited Interim Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Preferred Stock Series I [Member]
Preferred Stock Series H [Member]
Preferred Stock Series G [Member]
Preferred Stock Series F [Member]
Common Stock [Member]
Common Stock To Be Issued [Member]
Preferred Stock To Be Issued [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total Dalrada Financial Corps Stockholders Deficit [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Jun. 30, 2022 $ 100 $ 50 $ 360,855 $ 1,066,925 $ 104,627,032 $ (121,436,490) $ (50,673) $ (15,432,201) $ 479,019 $ (14,953,182)
Beginning balance, shares at Jun. 30, 2022 0 0 10,002 5,000 72,174,620                
Common stock issued for conversion of convertible notes, accrued interest, and premium $ 34,065 1,077,332 1,111,397 1,111,397
Common stock issued for conversion of convertible notes, accrued interest, and premium, shares         6,813,021                
Common stock issues pursuant to acquisitions $ 4,167 (175,000) 343,183 172,350 172,350
Common stock issues pursuant to acquisitions, shares         833,333                
Stock-based compensation $ 2,500 (175,000) 640,017 467,517 467,517
Stock-based compensation, shares         500,000                
Net loss (3,617,789) (3,617,789) 447,613 (3,170,176)
Foreign currency translation 63,762 63,762 63,762
Ending balance, value at Sep. 30, 2022 $ 100 $ 50 $ 401,587 716,925 106,687,564 (125,054,279) 13,089 (17,234,964) 926,632 (16,308,332)
Ending balance, shares at Sep. 30, 2022 0 0 10,002 5,000 80,320,974                
Beginning balance, value at Jun. 30, 2022 $ 100 $ 50 $ 360,855 1,066,925 104,627,032 (121,436,490) (50,673) (15,432,201) 479,019 (14,953,182)
Beginning balance, shares at Jun. 30, 2022 0 0 10,002 5,000 72,174,620                
Net loss                         (11,698,139)
Warrants issued pursuant to acquisitions                         0
Ending balance, value at Mar. 31, 2023 $ 100 $ 50 $ 431,187 317,925 109,222,356 (133,492,861) (21,177) (23,542,420) 837,251 (22,705,169)
Ending balance, shares at Mar. 31, 2023 0 0 10,002 5,000 86,240,807                
Beginning balance, value at Jun. 30, 2022 $ 100 $ 50 $ 360,855 1,066,925 104,627,032 (121,436,490) (50,673) (15,432,201) 479,019 (14,953,182)
Beginning balance, shares at Jun. 30, 2022 0 0 10,002 5,000 72,174,620                
Ending balance, value at Jun. 30, 2023 $ 351 $ 150 $ 100 $ 50 $ 443,478 192,925 145,251,822 (141,729,009) (50,848) 4,109,019 143,817 4,252,836
Ending balance, shares at Jun. 30, 2023 35,108 15,022 10,002 5,000 88,699,139                
Beginning balance, value at Sep. 30, 2022 $ 100 $ 50 $ 401,587 716,925 106,687,564 (125,054,279) 13,089 (17,234,964) 926,632 (16,308,332)
Beginning balance, shares at Sep. 30, 2022 0 0 10,002 5,000 80,320,974                
Common stock issued for conversion of convertible notes, accrued interest, and premium $ 20,808 315,283 336,091 336,091
Common stock issued for conversion of convertible notes, accrued interest, and premium, shares         4,161,500                
Common stock issues pursuant to acquisitions $ 5,875 (286,650) 356,234 75,459 75,459
Common stock issues pursuant to acquisitions, shares         1,175,000                
Stock-based compensation 901,721 901,721 901,721
Net loss (4,413,018) (4,413,018) (69,147) (4,482,165)
Foreign currency translation (34,129) (34,129) (34,129)
Ending balance, value at Dec. 31, 2022 $ 100 $ 50 $ 428,270 430,275 108,260,802 (129,467,297) (21,040) (20,368,840) 857,485 (19,511,355)
Ending balance, shares at Dec. 31, 2022 0 0 10,002 5,000 85,657,474                
Stock-based compensation 815,454 815,454 815,454
Net loss (4,025,564) (4,025,564) (20,234) (4,045,798)
Foreign currency translation (137) (137) (137)
Common stock issued pursuant to acquisitions $ 2,917 (112,350) 146,100 36,667 36,667
Common stock issued pursuant to acquisitions, shares         583,333                
Ending balance, value at Mar. 31, 2023 $ 100 $ 50 $ 431,187 317,925 109,222,356 (133,492,861) (21,177) (23,542,420) 837,251 (22,705,169)
Ending balance, shares at Mar. 31, 2023 0 0 10,002 5,000 86,240,807                
Beginning balance, value at Jun. 30, 2023 $ 351 $ 150 $ 100 $ 50 $ 443,478 192,925 145,251,822 (141,729,009) (50,848) 4,109,019 143,817 4,252,836
Beginning balance, shares at Jun. 30, 2023 35,108 15,022 10,002 5,000 88,699,139                
Stock-based compensation 1,109,642 1,109,642   1,109,642
Net loss (4,816,242) (4,816,242) (21,894) (4,838,136)
Foreign currency translation 85,208 85,208 85,208
Common stock issued pursuant to acquisitions $ 1,173 (37,500) 36,596 269 269
Common stock issued pursuant to acquisitions, shares         234,637                
Common stock issued pursuant to debt agreement $ 2,500 57,500 60,000 60,000
Common stock issued pursuant to debt agreement, shares         500,000                
Warrants issued pursuant to acquisitions 5,478 5,478 5,478
Ending balance, value at Sep. 30, 2023 $ 351 $ 150 $ 100 $ 50 $ 447,151 155,425 146,461,038 (146,545,251) 34,360 553,374 121,923 675,297
Ending balance, shares at Sep. 30, 2023 35,108 15,022 10,002 5,000 89,433,776                
Beginning balance, value at Jun. 30, 2023 $ 351 $ 150 $ 100 $ 50 $ 443,478 192,925 145,251,822 (141,729,009) (50,848) 4,109,019 143,817 4,252,836
Beginning balance, shares at Jun. 30, 2023 35,108 15,022 10,002 5,000 88,699,139                
Net loss                         (19,550,458)
Warrants issued pursuant to acquisitions                         16,974
Ending balance, value at Mar. 31, 2024 $ 511 $ 150 $ 100 $ 50 $ 481,294 128,925 162,968,758 (161,198,804) 14,707 2,395,691 63,154 2,458,845
Ending balance, shares at Mar. 31, 2024 51,059 15,022 10,002 5,000 96,258,774                
Beginning balance, value at Sep. 30, 2023 $ 351 $ 150 $ 100 $ 50 $ 447,151 155,425 146,461,038 (146,545,251) 34,360 553,374 121,923 675,297
Beginning balance, shares at Sep. 30, 2023 35,108 15,022 10,002 5,000 89,433,776                
Stock-based compensation 1,018,827 1,018,827 1,018,827
Net loss (5,406,198) (5,406,198) (33,982) (5,440,180)
Foreign currency translation (39,026) (39,026) (39,026)
Common stock issued pursuant to acquisitions $ 2,292 (26,500) 94,875 70,667 70,667
Common stock issued pursuant to acquisitions, shares         458,333                
Common stock issued pursuant to debt agreement $ 2,500 170,500 173,000 173,000
Common stock issued pursuant to debt agreement, shares         500,000                
Warrants issued pursuant to acquisitions 5,748 5,748 5,748
Common stock to be issued for private placement 604,000 604,000 604,000
Ending balance, value at Dec. 31, 2023 $ 351 $ 150 $ 100 $ 50 $ 451,943 732,925 147,750,988 (151,951,449) (4,666) (3,019,608) 87,941 (2,931,667)
Ending balance, shares at Dec. 31, 2023 35,108 15,022 10,002 5,000 90,392,109                
Conversion of related party notes to preferred stock $ 160 13,318,783 13,318,943 13,318,943
Conversion of related party notes to preferred stock, shares 15,951                        
Common stock issued pursuant to consulting agreement $ 6,000 235,200 241,200 241,200
Common stock issued pursuant to consulting agreement, shares         1,200,000                
Stock-based compensation 1,077,390 1,077,390 1,077,390
Net loss (9,247,355) (9,247,355) (24,787) (9,272,142)
Foreign currency translation 19,373 19,373 19,373
Warrants issued pursuant to acquisitions 5,748 5,748 5,748
Common stock issued pursuant to private placement $ 23,351 (604,000) 580,649
Common stock issued pursuant to private placement, shares         4,666,665                
Ending balance, value at Mar. 31, 2024 $ 511 $ 150 $ 100 $ 50 $ 481,294 $ 128,925 $ 162,968,758 $ (161,198,804) $ 14,707 $ 2,395,691 $ 63,154 $ 2,458,845
Ending balance, shares at Mar. 31, 2024 51,059 15,022 10,002 5,000 96,258,774